European Commission grants orphan drug status to Eisai’s amatuximab…
The investigational monoclonal antibody amatuximab , has been granted orphan drug designation for the treatment of malignant mesothelioma by the European Commission.
Endicott IBM health study limited but telling
The data are in, but the controversy continues. The latest chapter of the story of how chemicals used by IBM Corp. affected residents and workers in Endicott unfolded Thursday night with a presentation of a federal study of cancer rates among former em…
Mesothelioma survival more than doubles with radiation before surgery
Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly disease, compared to treating with surgery first.
Report Summarizes Cisplatin Therapy Study Findings from I.L. Cregan and Co-Researchers
Editor at Biotech Week — Research findings on Drugs and Therapies are discussed in a new report.
Making lives easier, helping firms to thrive – that’s what making law should be all about
It’s been a busy start to 2014 as I have been continuing to steer the Mesothelioma Bill through Parliament.
European Commission Grants Orphan Drug Status to Eisai’s…
The investigational monoclonal antibody amatuximab , has today been granted orphan drug designation for the treatment of malignant mesothelioma by the European Commission.
Asbestos fight: Sunderland electrician launches legal action over mesothelioma
A RETIRED electrician diagnosed with an asbestos-related cancer has launched a legal fight to investigate how he was exposed to the deadly dust.
Radiation Before Surgery More Than Doubles Mesothelioma Survival
Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly disease, compared to treating with surgery first.
Bill is ‘unfair’ to some victims nof asbestos
Last week saw the final stage of the Westminster Bill which will provide compensation for people who contracted Mesothelioma because of exposure to asbestos, but had to date been denied compensation because their employers had gone out of business, or …
Studies aim to address urgent need to identify possible new methods for mesothelioma treatment
Mesothelioma is a very aggressive cancer associated with asbestos exposure, which is usually diagnosed in an advanced stage.
Generous program helps improve lives
My brother-in-law is 83 and in the final stages of mesothelioma, unable to get around his home unassisted.
YEARS of exposure to asbestos led to the death of a West Dorset man, a coroner has ruled.
John Robert Jarvis, of Glebe Court, Beaminster, died after inhaling the toxic fibres during several years of working in maintenance, an inquest at County Hall heard.
Mesothelioma
Melissa Conrad Stppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology.
Searching for magic bullet against cancer caused by asbestos: One step closer?
So far no therapeutic strategy has proven effective against this deadly cancer and the prognosis remains very poor with only few exceptions.
The Asbestos Disease Awareness Organization (ADAO) Applauds U.S….
The Asbestos Disease Awareness Organization Applauds U.S. Senate for Passage of the Tenth Annual Resolution Establishing “National Asbestos Awareness Week” from April 1-7, 2014 )–The Asbestos Disease Awareness Organization , which combines education, …